PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.\', \'Department of Medicine D, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.\', \'Department of Pathology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.\', \'Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel.\', \'Department of Medical Laboratories, Barzilai University Medical Center, Ashkelon, Israel.\', \'Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel. Electronic address: labmomed@bgu.ac.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0272-6386(21)00509-610.1053/j.ajkd.2021.03.010
?:doi
?:hasPublicationType
?:journal
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
is ?:pmid of
?:pmid
?:pmid
  • 33839200
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all